Dainippon Sumitomo Pharma Co Ltd, 10% Owner at Myovant Sciences Ltd. (MYOV), bought 210,000 shares at $8.53 ($1.7M) on 2020-04-08, disclosed to the SEC on 2020-04-09.
Open-market purchase of $1.7M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.21 | 70,000 | $575K | 32.9% |
| 2 | $8.21 | 70,000 | $575K | 32.9% |
| 3 | $8.53 | 70,000 | $597K | 34.2% |
| Total | $8.32 avg | 210,000 | $1.7M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-01 | $4.3M | — | Filing → |
| MYOV | BUY | 2021-08-20 | $2.7M | — | Filing → |
| MYOV | BUY | 2021-08-18 | $3.0M | — | Filing → |